N-[(3-Bromoimidazo[1,2-a]pyrimidin-2-yl)methyl]-N-ethylethanamine | C11H15BrN4 | MD Topology | NMR | X-Ray

Visualize with JSmol

Molecule Information

Molecule Typeheteromolecule
Residue Name (RNME)3BTA
FormulaC11H15BrN4
IUPAC InChI Key
TWGXSJFNKGROMO-UHFFFAOYSA-N
IUPAC InChI
InChI=1S/C11H16BrN4/c1-3-15(4-2)8-9-10(12)16-7-5-6-13-11(16)14-9/h5-7,10H,3-4,8H2,1-2H3
IUPAC Name
N-[(3-bromoimidazo[1,2-a]pyrimidin-2-yl)methyl]-N-ethylethanamine
Common NameN-[(3-Bromoimidazo[1,2-a]pyrimidin-2-yl)methyl]-N-ethylethanamine
Canonical SMILES (Daylight)
CCN(C[C]1=[N]=[C]2=[N]=CC=CN2C=1Br)CC
Number of atoms31
Net Charge0
Forcefieldmultiple
Molecule ID186409
ChemSpider ID4188391
ChEMBL ID 1454979
Visibility Public
Molecule Tags

Format

Molecular Dynamics (MD) Files

Generating ...

X-Ray - Docking Files

Generating ...

NMR Parameters

1H NMR Spectrum

Generating ...

Fragment-Based Charges

No charge assignments available. Use the button above to use OFraMP fragment-based charge assignment.

Topology History

Processing Information

QM Processing Stage

Click table to toggle details.

Processing Stage Template Semi-Empirical QM (QM0) DFT QM (QM1) DFT Hessian QM (QM2)
Calculation None Energy Minization Energy Minization Hessian
Level of Theory None Semi-Empirical / SCF DFT (B3LYP/6-31G*) DFT (B3LYP/6-31G*)
Default Size Limit (Atoms) 2000 500 50 40
Content of MD Topology
Charges Derived From None MOPAC Merz-Singh-Kollman Merz-Singh-Kollman
Geometry  User Provided Optimized Optimized Optimized
Non-Bonded Interactions Bonds Rule Based:

Parameters are asigned from existing parameters with a set of rules based on atom types and geometry.

Hessian Based:

Force constant are calculated from the QM potential. New parameters are created when no suitable parameters exists.

Angles
Dihedrals

Data

Current Processing StateCompleted
Total Processing Time34 days, 22:59:59 (hh:mm:ss)

Calculated Solvation Free Energy

Access to this feature is currently restricted

Submit New Solvation Free Energy Computation